ANO1 amplification and expression may serve as markers for distant metastasis in HNSCC, suggesting CaCC inhibitors as potential therapeutic agents.
ANO1 amplification and expression could be markers for distant metastasis in HNSCC. ANO1 overexpression affects cell properties linked to metastasis. Inhibitors of CaCCs could be used to inhibit the tumourigenic properties of ANO1, whereas activators developed to increase CaCC activity could have adverse effects.
Ayoub et al. (Tue,) studied this question.